Research Article
Osteopontin in relation to Prognosis following Coronary Artery Bypass Graft Surgery
Table 2
Plasma osteopontin levels in study population.
| Characteristic | Patients, (%) | Osteopontin, ng/mL Median (interquartile range) | value |
| Gender | | | | Female | 14 (10.7) | 110.8 (59.4, 200.0) | 0.103 | Male | 117 (89.3) | 76.9 (48.2, 149.0) |
| Diabetes | | | | Yes | 50 (38.5) | 83.8 (52.0, 160.0) | 0.590 | No | | 77.1 (49.4, 149.0) |
| Hyperlipidemia | | | | Yes | 113 (86.9) | 80.1 (50.5, 150.9) | 0.928 | No | | 72.5 (54.9, 149.0) |
| Hypertension | | | | Yes | 121 (93.1) | 80.1 (50.5, 149.0) | 0.452 | No | | 76.9 (54.9, 221.0) |
| Smoking | | | | Yes | 70 (53.8) | 75.0 (45.5, 134.0) | 0.071 | No | | 88.5 (54.9, 167.0) |
| Family history of coronary disease | | | | Yes | 62 (48.1) | 81.3 (52.0, 160.0) | 0.607 | No | | 76.9 (48.9, 134.0) |
|
|